Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2025Frontiers in Health ServicesOpen Access

Cost-effectiveness of chemotherapy for advanced and recurrent cervical cancer: a systematic review

View Full Paper
Ask AI
Bookmark
Share

Authors

KIKatsuaki Inami

Discussion

Loading...

Member takes

Overview

Systematic review shows cost-effectiveness of chemotherapy in cervical cancer, indicating a need for value-based approaches.

Key Points

  • Traditional platinum-based chemotherapy consistently demonstrates cost-effectiveness, with ICERs below common willingness-to-pay thresholds.
  • Adding bevacizumab has survival benefits but leads to higher ICERs, raising cost concerns in treatment.
  • Immunotherapy like pembrolizumab shows potential, yet often surpasses willingness-to-pay thresholds in various settings.
  • Cost-effectiveness varies globally, highlighting the importance of localized pricing and healthcare considerations.

Cite This Study

Katsuaki Inami (2025) studied this question.

synapsesocial.com/papers/689a0939e6551bb0af8ce911https://doi.org/10.3389/frhs.2025.1616223
View Full Paper
Ask AI
Bookmark
Share